methyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate

Catalog No. :
ACJUBQ287
CAS No. :
1798842-93-9
Molecular Formula :
C20H30BNO6
Molecular Weight :
391.27

IUPAC Name:methyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate

methyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$666.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
IUPAC Namemethyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Molecular FormulaC20H30BNO6
Molecular Weight391.27
SMILESCOC(=O)C(NC(=O)OC(C)(C)C)C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1
InChI KeyHAXISXDYOUUANB-UHFFFAOYSA-N
SynonymBenzeneacetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester;Methyl 2-((tert-butoxycarbonyl)amino)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
CAS No.1798842-93-9

Synthetic Route by SureRoute

1. ACJUBQ287 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACLIFQ901 route compound structure diagram
    ACLIFQ901709665-73-6 In Stock
  4. Then
  5. ACJUBQ287 route product structure diagram
    ACJUBQ2871798842-93-9
Inquiry

2. ACJUBQ287 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJUBQ287 route product structure diagram
    ACJUBQ2871798842-93-9
Inquiry

Comments (0)